TITLE

Arzerra net sales in Q2 2012 were GBP 14.9 million

PUB. DATE
August 2012
SOURCE
Biotech Financial Reports;Aug2012, Vol. 19 Issue 8, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the net sales of Copenhagen, Denmark-based biotechnology company Genmab A/S's Arzerra (ofatumumab) in the second quarter of 2012. It states that net sales of Arzerra reached 14.9 million pounds which consists of net sales in the U.S. of 9.4 million pounds and 5.5 million pounds in the rest of the world. It indicates that Genman expects to receive a royalty payment of about 27 million Danish krone.
ACCESSION #
78305863

 

Related Articles

  • DATAMONITOR: Genmab A/S.  // Genmab A/S SWOT Analysis;Nov2010, p1 

    A company profile of Genmab A/S, which is a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases, is presented. An overview of the company is given, along with key facts including contact information,...

  • Company Overview.  // Genmab A/S SWOT Analysis;May2007, p4 

    An overview of Genmab A/S, a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases, is presented. Data is included on revenues generated in fiscal year ended December 2006, the number of employees, as well...

  • Genmab A/S SWOT Analysis.  // Genmab A/S SWOT Analysis;Oct2007, p1 

    A company profile of Genmab A/S, a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases , is presented. An overview of the company is given, along with key facts including contact information, number of...

  • SWOT Analysis.  // Genmab A/S SWOT Analysis;Oct2007, p5 

    A business analysis of Genmab A/S, a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company....

  • Genmab A/S SWOT Analysis.  // Genmab A/S SWOT Analysis;May2007, p1 

    A company profile of Genmab A/S, a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases, is presented. An overview of the company is given, along with key facts including contact information, number of...

  • Key Facts.  // Genmab A/S SWOT Analysis;May2007, p4 

    Key facts about Genmab A/S, a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases, are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and...

  • SWOT Analysis.  // Genmab A/S SWOT Analysis;May2007, p5 

    A business analysis of Genmab A/S, a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company....

  • Company Overview.  // Genmab A/S SWOT Analysis;Oct2007, p4 

    An overview of Genmab A/S, a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases, is presented. Data is included on revenues generated in fiscal year ended December 2006, as well as principal business...

  • Key Facts.  // Genmab A/S SWOT Analysis;Oct2007, p4 

    Key facts about Genmab A/S, a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases, are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics